Immunotherapy and monoclonal antibody therapies.

Regulation of Monoclonal Antibody Immunotherapy by FcγRIIB.

Immunotherapy with monoclonal antibody (Mab) in pancreatic adenocarcinoma.

Recent Advances in Monoclonal Antibody Therapies for Multiple Sclerosis.

Monoclonal Antibody Complexes for Control of Established Tumors.

Elotuzumab, First-in-Class Monoclonal Antibody Immunotherapy, Improves Outcomes in Patients with Multiple Myeloma.

Nivolumab, anti-programmed death-1 (PD-1) monoclonal antibody immunotherapy: Role in advanced cancers.

Monoclonal antibody immunotherapy in nude mice persistently infected with Cryptosporidium parvum.

Immunotherapy of cancer with antibody.

Monoclonal antibody to biotin.

Immunotherapy and lung cancer: current developments and novel targeted therapies.

Distribution of a breast-directed I-131-radiolabeled monoclonal antibody in blood and bone marrow: implications for radiation immunotherapy.

Immunotherapy of advanced renal cell carcinoma: Current and future therapies.

Targeted therapies and immunotherapy in non-small-cell lung cancer.

Immunotherapy in Melanoma: Recent Advances and Promising New Therapies.

Monoclonal antibody therapy of cancer.

Monoclonal antibody engineering in plants.

Breast cancer immunotherapy: monoclonal antibodies and peptide-based vaccines.

HER2 and immunotherapy using monoclonal antibodies in colorectal cancer.

Novel antibody-based proteins for cancer immunotherapy.

Bispecific antibody platforms for cancer immunotherapy.

Tumor antigen-targeting monoclonal antibody-based immunotherapy: Orchestrating combined strategies for the development of long-term antitumor immunity.

A new form of specific targeting cancer immunotherapy using anti-tumor monoclonal antibody-conjugated lymphokine-activated killer cells.

Monoclonal antibody-based immunotherapy of ovarian cancer: targeting ovarian cancer cells with the B7-H3-specific mAb 376.96.

When are signal transduction targeted therapies acting as immunotherapy?

Suggest Documents

Regulation of Monoclonal Antibody Immunotherapy by FcγRIIB.

Immunotherapy with monoclonal antibody (Mab) in pancreatic adenocarcinoma.

Recent Advances in Monoclonal Antibody Therapies for Multiple Sclerosis.

Monoclonal Antibody Complexes for Control of Established Tumors.

Elotuzumab, First-in-Class Monoclonal Antibody Immunotherapy, Improves Outcomes in Patients with Multiple Myeloma.

Nivolumab, anti-programmed death-1 (PD-1) monoclonal antibody immunotherapy: Role in advanced cancers.

Monoclonal antibody immunotherapy in nude mice persistently infected with Cryptosporidium parvum.

Immunotherapy of cancer with antibody.

Monoclonal antibody to biotin.

Immunotherapy and lung cancer: current developments and novel targeted therapies.

Distribution of a breast-directed I-131-radiolabeled monoclonal antibody in blood and bone marrow: implications for radiation immunotherapy.

Immunotherapy of advanced renal cell carcinoma: Current and future therapies.

Targeted therapies and immunotherapy in non-small-cell lung cancer.

Immunotherapy in Melanoma: Recent Advances and Promising New Therapies.

Monoclonal antibody therapy of cancer.

Monoclonal antibody engineering in plants.

Breast cancer immunotherapy: monoclonal antibodies and peptide-based vaccines.

HER2 and immunotherapy using monoclonal antibodies in colorectal cancer.

Novel antibody-based proteins for cancer immunotherapy.

Bispecific antibody platforms for cancer immunotherapy.

Tumor antigen-targeting monoclonal antibody-based immunotherapy: Orchestrating combined strategies for the development of long-term antitumor immunity.

A new form of specific targeting cancer immunotherapy using anti-tumor monoclonal antibody-conjugated lymphokine-activated killer cells.

Monoclonal antibody-based immunotherapy of ovarian cancer: targeting ovarian cancer cells with the B7-H3-specific mAb 376.96.

When are signal transduction targeted therapies acting as immunotherapy?

Immunotherapy and monoclonal antibody therapies.

Recommend Documents

Follow Us